Health
Sacubitril/Valsartan Treatment for HFpEF Shown to Reduce NT-proBNP Levels – AJMC.com Managed Markets Network
Wanting more data on the benefits of sacubitril/valsartan vs renin angiotensin system inhibitor background therapy, investigators…
Among several measures evaluated in a 24-week, randomized, double-blind, parallel group clinical trial comparing outcomes among patients with heart failure with preserved ejection fraction (HFpEF; left ventricular ejection fraction > 40%), sacubitril/valsartan…
Continue Reading
-
General22 hours agoWest Indies vs Australia live: Second Test, day two from Grenada
-
Noosa News24 hours agoRailed! at Wynnum Fringe: All the Details
-
General20 hours agoDear God! It’s 2028 | The Spectator Australia
-
General23 hours agoAnthony Albanese to champion ‘Australian independence’ within US alliance